← Leaderboards
Paul David Benya
Children'S Hospital Of Los Angeles
$1,013,449
Attributed
$2,026,898
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $410.5K · FY2009–15$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,026,898 · 2
By mechanism
R01$2,026,898 · 2
Top collaborators
- Tai-Lan Tuan6 shared
Most similar at Children'S Hospital Of Los Angeles
Same institution · by research overlap
- Anoopindar Bhalla$2,636,155
- Mimi Susan Kim$656,869
Others in their field
Top investigators on “Fibrin”
- Robert T Tranquillo · University Of Minnesota Twin Cities$16,524,965
- Steven Kyle Grinspoon · Massachusetts General Hospital$15,631,556
- Pamela Susan Douglas · Duke University$15,631,556
- Bruce Furie · Beth Israel Deaconess Medical Center$15,095,734
- Guy L Reed · Harvard University (Sch Of Public Hlth)$12,951,913
- Peter D Caravan · Massachusetts General Hospital$12,495,120
Research focus
FibrinProductionPlasminogen Activator Inhibitor 1Small Interfering RnaFibroblastsPreventHispanicsOverexpressionSkinRna InterferenceTumorAffectCicatrixAsiansBaseCollagenAfricanKeloidValidationTherapeutic TargetExhibitsFibrosisClinical ApplicationCell Line
Grant awards (6)
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models$304,183
R01 · FY2015 · GM
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models$304,183
R01 · FY2014 · GM
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models$293,537
R01 · FY2013 · GM
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models$319,683
R01 · FY2012 · GM
ECM Remodeling in Excessive Fibroplasia$394,799
R01 · FY2010 · GM
ECM Remodeling in Excessive Fibroplasia$410,513
R01 · FY2009 · GM